Study discovers how new blood serum test detect neurodegenerative disorder
May 23, 2025
  • Read Ecopy
  • Circulation
  • Advertise
  • Careers
  • About Us
  • Contact Us
Organiser
  • ‌
  • Bharat
    • Assam
    • Bihar
    • Chhattisgarh
    • Jharkhand
    • Maharashtra
    • View All States
  • World
    • Asia
    • Europe
    • North America
    • South America
    • Africa
    • Australia
    • Global Commons
  • Editorial
  • International
  • Opinion
  • Op Sindoor
  • More
    • Analysis
    • Sports
    • Defence
    • RSS in News
    • Politics
    • Business
    • Economy
    • Culture
    • Special Report
    • Sci & Tech
    • Entertainment
    • G20
    • Azadi Ka Amrit Mahotsav
    • Vocal4Local
    • Web Stories
    • Education
    • Employment
    • Books
    • Interviews
    • Travel
    • Law
    • Health
    • Obituary
    • Podcast
MAGAZINE
  • ‌
  • Bharat
    • Assam
    • Bihar
    • Chhattisgarh
    • Jharkhand
    • Maharashtra
    • View All States
  • World
    • Asia
    • Europe
    • North America
    • South America
    • Africa
    • Australia
    • Global Commons
  • Editorial
  • International
  • Opinion
  • Op Sindoor
  • More
    • Analysis
    • Sports
    • Defence
    • RSS in News
    • Politics
    • Business
    • Economy
    • Culture
    • Special Report
    • Sci & Tech
    • Entertainment
    • G20
    • Azadi Ka Amrit Mahotsav
    • Vocal4Local
    • Web Stories
    • Education
    • Employment
    • Books
    • Interviews
    • Travel
    • Law
    • Health
    • Obituary
    • Podcast
Organiser
  • Home
  • Bharat
  • World
  • Operation Sindoor
  • Editorial
  • Analysis
  • Opinion
  • Culture
  • Defence
  • International Edition
  • RSS in News
  • Magazine
  • Read Ecopy
Organiser Weekly is Hiring!
Home World

Study discovers how new blood serum test detect neurodegenerative disorder

Neurodegenerative disorders known as synucleinopathies are brought on by an abnormal buildup of the protein a-synuclein found in the brain and neurons. By producing "seeds," improperly folded a-synuclein attracts additional a-synuclein proteins to form larger clumps

by WEB DESK
May 30, 2023, 11:00 pm IST
in World, Health
FacebookTwitterWhatsAppTelegramEmail

Synucleinopathies are neurodegenerative disorders caused by an aberrant accumulation of a-synuclein, a protein present in the brain and neurons. Incorrect a-synuclein folding results in the production of’seeds,’ which attract more a-synuclein proteins to build larger clumps. Although a-synuclein seeds have been discovered in numerous tissues and blood of patients suffering from synucleinopathies, their value as a biomarker is unclear.

Recently, in a study published in Nature Medicine, Associate Professor Ayami Okuzumi along with Senior Associate Professor Taku Hatano, both from the Juntendo University School of Medicine, Senior Assistant Professor Gen Matsumoto at the Nagasaki University School of Medicine, and Professor Nobutaka Hattori from Juntendo University Faculty of Medicine /RIKEN Center for Brain Science, present a novel assay that can efficiently detect a-synuclein seeds from a patient’s serum. In this assay, named immunoprecipitation-based real-time quaking-induced conversion (IP/RT-QuIC), the a-synuclein seeds are isolated from the patient’s serum through immunoprecipitation (protein separation using an antibody binding only to the target protein) followed by rapid amplification by real-time quaking-induced conversion (amplification induced by vigorous shaking). This method is highly sensitive, as it can detect serum a-synuclein seed concentrations as small as 1000pg/ml. This comes as great news since most existing diagnostic methods require cerebrospinal fluid for synuclein detection. The current study was made available/published on May 30, 2023.

Sharing the objective of their study, Professor Hattori and his team explains, “In this study, we validated the usefulness of our novel assay system, IP/RT-QuIC, as a diagnostic marker of synucleinopathies. We propose that the fibril morphology of serum a-synuclein seeds and aggregates derived by IP/RT-QuIC can discriminate between Parkinson’s disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA).”

The research team demonstrated that IP/RT-QuIC detected a-synuclein seeds efficiently in patients with neurodegenerative diseases and could distinguish them from people without degenerative diseases (controls). Next, they studied the structural properties of the amplified seeds using transmission electron microscopy (TEM). They observed that the synuclein seed structure varied with the type of synucleinopathy. PD and DLB seeds showed paired filaments whereas MSA seeds had two distinct structures – twisted and straight filaments. This finding was confirmed that IP/RT-QuIC coupled with TEM can differentiate between synucleinopathies based on disease specific seed structure.

Further, when the researchers transduced amplified seeds into the HEK293T cell line stably expressing GFP-fused human a-synuclein with p.A53T mutation (in vitro) and injected seeds into mouse brains (in vivo), the seeds retained their aggregate forming capacity and diseases-specific seed structure. These aggregates displayed different morphologies depending on the disease type. Thus, specific synucleinopathies can be diagnosed by IP/RT-QuIC from the structural differences of the a-synuclein seeds and their aggregates.

This technique could help provide a quick and efficient diagnosis to patients. Professor Hattori and his team explains, “At present, a neurologist’s consultation is necessary to diagnose synucleinopathies. However, using IP/RTQuIC, a general internist can make the diagnosis. Therefore, more patients with synucleinopathies may be diagnosed with precision and could receive appropriate treatment at an earlier stage.”

The authors conclude with their future vision, “Our new IP/RT-QuIC assay may have many future applications as a biomarker for precise diagnosis and monitoring of treatment of neurodegenerative diseases in clinical trials. This simple diagnostic method will enable establishment of personalised therapy options for synucleinopathies.”

(with inputs from ANI)

 

 

 

 

Topics: proteinBlood serum testNeurodegenerative disorderSynucleinopathiesSeruma-synuclein seeds
ShareTweetSendShareSend
Subscribe Organiser YouTube Channel
Previous News

How Artificial Intelligence could be used to improve lives of poor

Next News

Remembering Devi Ahilyabai Holkar on her birth anniversary

Related News

Representative image

Researchers discover how body’s natural killer cells protects from cancer

Representative image

Study finds new gene in progression of Huntington’s disease

Representative image

Nanotechnology breakthrough could transform Alzheimer’s care

Representative image

Consuming too much protein is risky for arteries, and this amino acid is to blame: Study

Representative image

How lack of sleep can harm brain, finds study

Representative image

Most milk alternatives lack nutritional value of cow’s milk: Study

Load More

Comments

The comments posted here/below/in the given space are not on behalf of Organiser. The person posting the comment will be in sole ownership of its responsibility. According to the central government's IT rules, obscene or offensive statement made against a person, religion, community or nation is a punishable offense, and legal action would be taken against people who indulge in such activities.

Latest News

Karnataka Minister Priyank Kharge
(Right)

Karnataka: Congress under fire over alleged mob attack on BJP MLC; Demands mount for Priyank Kharge’s ouster

Screenshot

Operation Sindoor: Eight F-16s, four JF-17s downed; Pakistan Air Force losses exceed 3.35 billion dollar – Report

Former J&K Governor Satya Pal Malik

J&K: Satya Pal Malik, five others named in CBI chargesheet over Kiru Hydropower contract irregularities

INSV Kaundinya

Who was Kaundinya, the ancient mariner behind the Indian Navy’s new ‘Stitched Ship’?

Key associate of KLF Bhagwant Singh

NIA arrests key Khalistani Bhagwant Singh involved in Amritsar temple grenade attack case

Accused arrested, from left to right- Tufail Ahmad, Shehzad Wahab, Mohammad Tarif and Nauman Ilahi

Where are Shehzad, Nauman, Tufail, and Co.? Media obsession with Jyoti Malhotra eclipses other accused in ISI spy probe

Communist and leftists condole the killing of anti-national Maoists

Red Flags of Hypocrisy: Communist support for Maoists and terrorists like Basavaraju exposed

ABVP denounces Ashoka University Vice Chancellor for hailing Prof Mahmudabad on getting interim bail

Ashoka University VC’s hailing Prof Mahmudabad on getting interim bail, undermines national interest: ABVP

Sikhs beings forcefully converted to Christianity in Pilibhit

Illegal conversion in Uttar Pradesh: 3000 Sikhs converted to Christianity in Pilibhit, probe on

The CPEC expansion is the first trilateral meeting between China, Pakistan and Afghanistan since Operation Sindoor post the Pahalgam attack

Is China-Afghan pact for CPEC a strategic challenge to India’s regional influence?

  • Privacy
  • Terms
  • Cookie Policy
  • Refund and Cancellation
  • Delivery and Shipping

© Bharat Prakashan (Delhi) Limited.
Tech-enabled by Ananthapuri Technologies

  • Home
  • Search Organiser
  • Bharat
    • Assam
    • Bihar
    • Chhattisgarh
    • Jharkhand
    • Maharashtra
    • View All States
  • World
    • Asia
    • Africa
    • North America
    • South America
    • Europe
    • Australia
    • Global Commons
  • Editorial
  • Operation Sindoor
  • Opinion
  • Analysis
  • Defence
  • Culture
  • Sports
  • Business
  • RSS in News
  • Entertainment
  • More ..
    • Sci & Tech
    • Vocal4Local
    • Special Report
    • Education
    • Employment
    • Books
    • Interviews
    • Travel
    • Health
    • Politics
    • Law
    • Economy
    • Obituary
    • Podcast
  • Subscribe Magazine
  • Read Ecopy
  • Advertise
  • Circulation
  • Careers
  • About Us
  • Contact Us
  • Policies & Terms
    • Privacy Policy
    • Cookie Policy
    • Refund and Cancellation
    • Terms of Use

© Bharat Prakashan (Delhi) Limited.
Tech-enabled by Ananthapuri Technologies